AstraZeneca COVID-19 Vaccine Woes Continue as Questions are Raised over US Trial Data March 24, 2021 Auto Bot News 0 After releasing US Phase III trial data for AZD1222, more questions have been raised with AstraZeneca concerning potentially outdated information that could provide an incomplete view of efficacy.